Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: DR Nikki Vickaryous

Back to Search
Jacobs BM, Vickaryous N, Giovannoni G, Proitsi P, Waters S, Dobson R ( 2024 ) . Plasma proteomic profiles of UK Biobank participants with multiple sclerosis . Annals of Clinical and Translational Neurology vol. 11 , ( 3 ) 698 - 709 .
Dobson R, Holden D, Vickaryous N, Bestwick J, George K, Sayali T, Bianchi L, Wafa M et al. ( 2023 ) . A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis . Multiple Sclerosis Journal vol. 30 , ( 1 ) 63 - 70 .
Zaloum SA, Wood CH, Tank P, Upcott M, Vickaryous N, Anderson V, Baker D, Chance R et al. ( 2023 ) . Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination . Multiple Sclerosis Journal vol. 29 , ( 8 ) 979 - 989 .
Kuri A, Vickaryous N, Awad A, Jacobs BM, Dobson R ( 2022 ) . Vitamin D genetic risk scores in multiple sclerosis . Journal of Neurology vol. 270 , ( 2 ) 1030 - 1035 .
Kuri A, Vickaryous N, Jacobs BM, Awad A, Dobson R ( 2022 ) . 134 Predictors of serum vitamin D level in multiple sclerosis . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 9 )
Tallantyre E, Vickaryous N, Richards A, Rios F, George K, Scurr M, Loveless S ( 2022 ) . T-cell response following COVID booster vaccination in seronegative people with multiple sclerosis . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. ( 2022 ) . Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 64 ,
Tallantyre EC, Vickaryous N, Anderson V, Asardag AN, Baker D, Bestwick J, Bramhall K, Chance R et al. ( 2021 ) . COVID‐19 Vaccine Response in People with Multiple Sclerosis . Annals of Neurology vol. 91 , ( 1 ) 89 - 100 .
Vickaryous N, Jitlal M, Jacobs BM, Middleton R, Chandran S, MacDougall NJJ, Giovannoni G, Dobson R ( 2020 ) . Remote testing of vitamin D levels across the UK MS population—A case control study . PLOS ONE vol. 15 , ( 12 )
Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, Dobson R ( 2020 ) . Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom . BMC Public Health vol. 20 , ( 1 )
Vickaryous N, Polanco-Echeverry G, Morrow S, Tomlinson I ( 2008 ) . Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome . Br J Cancer vol. 99 , ( 10 ) 1726 - 1728 .
McCart AE, Vickaryous NK ( 2008 ) . Apc mice: Models, modifiers and mutants . Pathology - Research and Practice vol. 204 , ( 7 ) 479 - 490 .
Dobson R, Holden D, Vickaryous N, Bestwick J, George K, Sayali T, Bianchi L, Wafa M et al. . A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis .
Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, Dobson R . Epidemiology of Epstein-Barr Virus infection and Infectious Mononucleosis in the United Kingdom .
Jacobs BM, Vickaryous N, Giovannoni G, Proitsi P, Waters S, Dobson R . Plasma proteomic profiles of UK Biobank participants with Multiple Sclerosis .
Vickaryous N, Jitlal M, Jacobs BM, Middleton R, Chandran S, MacDougall NJJ, Giovannoni G, Dobson R . Remote testing of vitamin D levels across the UK MS population – a case control study .
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. . Response to COVID-19 booster vaccinations in seronegative people with MS .
Back to Search